Litcius/Paper detail

Clinical and genetic risk factors define two risk groups of extracranial malignant rhabdoid tumours (eMRT/RTK)

Karolina Nemes, Susanne Bens, D. Yu. Kachanov, M. V. Teleshova, Péter Hauser, Thorsten Simon, Stephan Tippelt, Wilhelm Woessmann, Olaf Beck, Christian Flotho, Lorenz Grigull, Pablo Hernáiz Driever, Paul‐Gerhardt Schlegel, Claudia Khurana, Kathrin Hering, R Kolb, Alfred Leipold, Floor Abbink, Maria João Gil‐da‐Costa, Martin Benesch, Kornelius Kerl, Stephen P. Lowis, Carmen Hernández Marqúes, Norbert Graf, Karsten Nysom, Christian Vokuhl, Patrick Melchior, Thomas Kröncke, Reinhard Schneppenheim, Uwe Kordes, Joachim Gerß, Reiner Siebert, Rhoikos Furtwängler, Michael C. Frühwald

2020European Journal of Cancer29 citationsDOI

Topics & Concepts

MedicineOncologyInternal medicineChromatin Remodeling and CancerRNA regulation and diseaseMechanisms of cancer metastasis
Clinical and genetic risk factors define two risk groups of extracranial malignant rhabdoid tumours (eMRT/RTK) | Litcius